Keycorp (KEY) 11.45 $KEY The Zacks Analyst Blog

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Keycorp (KEY) 11.45 $KEY

The Zacks Analyst Blog Highlights: KeyCorp, SunTrust Banks, Fifth Third Bancorp, BB&T and Comerica
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 8:30AM CDT
The Zacks Analyst Blog Highlights: KeyCorp, SunTrust Banks, Fifth Third Bancorp, BB&T and Comerica
FITB: 18.58 (-0.20), BBT: 36.38 (-0.29), STI: 41.37 (-0.51), KEY: 11.45 (-0.03), CMA: 44.00 (-0.63)

Zacks Industry Outlook Highlights: M&T Bank, KeyCorp, Webster Financial, Bank of New York Mellon and BofI Holding
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 8:30AM CDT
Zacks Industry Outlook Highlights: M&T Bank, KeyCorp, Webster Financial, Bank of New York Mellon and BofI Holding
BOFI: 15.34 (-0.75), MTB: 112.00 (-0.78), KEY: 11.45 (-0.03), BK: 38.80 (-0.40), WBS: 35.75 (+0.08)

What Spells Trouble Ahead for U.S. Banks?
Kalyan Nandy - Zacks Investment Research - Fri Jul 29, 4:42PM CDT
What Spells Trouble Ahead for U.S. Banks?
BOFI: 15.34 (-0.75), WABC: 46.64 (-0.19), MTB: 112.00 (-0.78), WFC: 47.70 (-0.11), KEY: 11.45 (-0.03), BK: 38.80 (-0.40), WBS: 35.75 (+0.08)

KeyCorp Closes Acquisition Of First Niagara Financial Group
PR Newswire - Fri Jul 29, 3:15PM CDT
KeyCorp (NYSE: KEY) announced today that it has closed its acquisition of First Niagara Financial Group, Inc. (NASDAQ: FNFG) ("First Niagara". Systems and client conversion is expected during the fourth quarter of 2016, subject to pending regulatory approval by the Office of the Comptroller of the Currency ("OCC" for the merger of First Niagara Bank into KeyBank.
FNFG: 10.18 (-0.02), KEY: 11.45 (-0.03)

Bank Stock Roundup: Q2 Earnings Coming to an End; KeyCorp, BB&T in Focus
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 10:26AM CDT
Over the last five trading days, we have seen the last phase earnings releases for the second quarter by U.S. banks.
FITB: 18.58 (-0.20), COF: 66.30 (-0.73), BBT: 36.38 (-0.29), JPM: 63.65 (-0.15), C: 42.99 (-0.43), STI: 41.37 (-0.51), WFC: 47.70 (-0.11), KEY: 11.45 (-0.03), PNC: 81.66 (-0.76), CMA: 44.00 (-0.63)

State Street (STT) Beats on Q2 Earnings as Expenses Fall
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 9:10AM CDT
Lower costs driven by a successful expense savings initiative led State Street's second-quarter 2016 operating earnings of $1.46 per share, which handily surpassed the Zacks Consensus Estimate of $1.26.
STT: 65.33 (-0.61), BBT: 36.38 (-0.29), KEY: 11.45 (-0.03), BK: 38.80 (-0.40)

New Strong Sell Stocks for July 27th
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 7:11AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Wednesday
TESS: 13.21 (-0.12), ALV: 103.25 (-2.60), AMC: 27.83 (-0.63), PRGX: 4.66 (unch), KEY: 11.45 (-0.03)

After Yesterday's Decline of 1.33%, Keycorp Offers Investors Better Value
Comtex SmarTrend(R) - Tue Jul 26, 12:57PM CDT
Keycorp (NYSE:KEY) traded in a range yesterday that spanned from a low of $11.44 to a high of $11.71. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $11.62 on volume of 14.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
KEY: 11.45 (-0.03)

Watch for Keycorp to Potentially Rebound After Falling 1.33% Yesterday
Comtex SmarTrend(R) - Tue Jul 26, 12:55PM CDT
Keycorp (NYSE:KEY) traded in a range yesterday that spanned from a low of $11.44 to a high of $11.71. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $11.62 on volume of 14.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
KEY: 11.45 (-0.03)

KeyCorp's (KEY) Q2 Earnings Miss on High Costs, Provisions
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 9:21AM CDT
In addition to a significant rise in provision for credit losses and operating expenses, a decline in non-interest income was there to dampen the results.
USB: 41.43 (-0.25), STI: 41.37 (-0.51), KEY: 11.45 (-0.03), CMA: 44.00 (-0.63)

Before Q2 Earnings Intensify, Sell These 3 Bank Stocks
Zacks Premium Research - Zacks Investment Research - Mon Jul 18, 3:51PM CDT
These banks are all sell-ranked, and they also stand to be less profitable because of the low interest rate environment which currently prevails.
KEY: 11.45 (-0.03), BKU: 29.26 (-0.33), BK: 38.80 (-0.40)

The Zacks Analyst Blog Highlights: JPMorgan Chase, Bank of the Ozarks, KeyCorp. and Citigroup
Zacks Equity Research - Zacks Investment Research - Mon Jul 18, 8:30AM CDT
The Zacks Analyst Blog Highlights: JPMorgan Chase, Bank of the Ozarks, KeyCorp. and Citigroup
JPM: 63.65 (-0.15), C: 42.99 (-0.43), KEY: 11.45 (-0.03), OZRK: 35.49 (-0.28)

Bank Stock Roundup: Q2 Earnings Season Kicks Off with JPMorgan Beat
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 2:05PM CDT
Due to the commencement of the Q2 earnings season, all eyes were on the banking sector over the last five trading sessions. JPMorgan proved analysts wrong by reporting an earnings beat on July 14.
RF: 8.90 (-0.12), COF: 66.30 (-0.73), BBT: 36.38 (-0.29), JPM: 63.65 (-0.15), C: 42.99 (-0.43), BAC: 14.13 (-0.20), KEY: 11.45 (-0.03), PNC: 81.66 (-0.76), BK: 38.80 (-0.40), CMA: 44.00 (-0.63), OZRK: 35.49 (-0.28)

KeyCorp Declares Quarterly Common Share Cash Dividend Of Eight And One Half Cents
PR Newswire - Wed Jul 13, 4:27PM CDT
KeyCorp (NYSE: KEY) announced today that its Board of Directors declared the following dividends for the third quarter of 2016:
KEY: 11.45 (-0.03)

KeyCorp's First Niagara Deal Gets Fed's Nod: What's Next?
Zacks Equity Research - Zacks Investment Research - Wed Jul 13, 6:22AM CDT
KeyCorp (KEY) announced the receipt of regulatory approval from the Federal Reserve for its proposed acquisition of First Niagara Financial Group Inc.
RY: 60.00 (-0.28), FNFG: 10.18 (-0.02), KEY: 11.45 (-0.03), CM: 74.46 (-0.51)

KeyCorp Receives Regulatory Approval For First Niagara Financial Group Merger
PR Newswire - Tue Jul 12, 3:20PM CDT
KeyCorp (NYSE: KEY) and First Niagara Financial Group, Inc. (NASDAQ: FNFG) ("First Niagara" announced today that KeyCorp has received regulatory approval from the Federal Reserve to complete the merger with First Niagara Financial Group.
FNFG: 10.18 (-0.02), KEY: 11.45 (-0.03)

Upgrade Alert for Keycorp (KEY)
Comtex SmarTrend(R) - Tue Jul 12, 3:42AM CDT
Keycorp (NYSE:KEY) was upgraded from Market Perform to Outperform at FBR Capital today. The stock closed yesterday at $11.22 on volume of 11.2 million shares, below average daily volume of 12.8 million. KeyCorp is a financial services holding company. The Company provides a wide range of retail and commercial banking, commercial leasing, investment management, consumer finance and investment banking products and services to individual, corporate and institutional clients.
KEY: 11.45 (-0.03)

Look for Shares of Keycorp to Potentially Pullback after Yesterday's 1.31% Rise
Comtex SmarTrend(R) - Mon Jul 11, 1:39PM CDT
Keycorp (NYSE:KEY) traded in a range yesterday that spanned from a low of $11.17 to a high of $11.36. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $11.29 on volume of 7.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
KEY: 11.45 (-0.03)

Keycorp Rises 1.31% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Jul 11, 1:38PM CDT
Keycorp (NYSE:KEY) traded in a range yesterday that spanned from a low of $11.17 to a high of $11.36. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $11.29 on volume of 7.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
KEY: 11.45 (-0.03)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 385

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Build-A-Bear Lawsuit Notice Carries a Date Problem

Updated Category News Views 26

Something is badly out of sequence in the Build-A-Bear shareholder alert, and that matters before anybody gets carried away by the legal boilerplate. The notice says investors who bought NYSE: BBW securities from March 28, 2026 through August 26, 2026 may be covered by a proposed federal securities class action. It also says the lead-plaintiff deadline is January 19,...

Continue Reading

Top 5 Most Recently Viewed Articles

NuCana Discontinues Phase 2 Colorectal Cancer Study

Updated Category News Views 146

NuCana Provides Update on Phase 2 Randomized Colorectal Cancer Study NuTide:323 Study Discontinued Following Initial Analysis Ongoing Studies Show Promise with NUC-7738 and Pembrolizumab NuCana plc (NASDAQ: NCNA) has shared important updates about its clinical trials focused on innovative treatments for colorectal cancer. The company has made the decision to discontinue...

Continue Reading
Brøndbyernes IF Football Meeting - Key Highlights Recap

Updated Category News Views 179

Overview of the Annual General Meeting for Brøndbyernes IF Football A/S BRØNDBYERNES I.F. FODBOLD A/S CVR-nr. 83 93 34 10 This report summarizes the outcomes of the annual general meeting conducted by Brøndbyernes IF Football A/S. Key Date and Location The annual shareholders meeting took place, gathering stakeholders and shareholders at the club's headquarters. A...

Continue Reading
Uncovering the Wealth from Investing in BlackRock

Updated Category News Views 314

The Potential Growth of $1000 in BlackRock Investors often wonder how their money would grow over time if invested in strong companies. Recently, we looked into BlackRock, Inc., known by its stock ticker BLK. Over a span of 15 years, investing just $1000 into BlackRock stocks would yield an impressive value today. According to current evaluations, if you had made that...

Continue Reading
Zealand Pharma Advances Glepaglutide Approval for SBS Treatment

Updated Category News Views 267

Glepaglutide Submission to EMA Marks Significant Progress Zealand Pharma A/S, a pioneering biotechnology company, has recently shared exciting news about its Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for its innovative drug, glepaglutide. This long-acting GLP-2 analog is specifically designed for treating adults suffering from short...

Continue Reading
Seven Gables Real Estate Partners with Local Logic for Insights

Updated Category News Views 40

Seven Gables Real Estate Partners with Local Logic In a significant move that underscores their dedication to innovation, Seven Gables Real Estate has announced an exciting partnership with Local Logic, a leader in location intelligence. This collaboration is set to incorporate Local Logic's cutting-edge products—Local Content, Local Search, and NeighborhoodWrap—into...

Continue Reading